NCT02942862

Brief Summary

Colon cancer is a very common cancer. Prognosis and adjuvant treatment depend on the pathological results. Histoprognostic new factors have recently been published by several authors, but their validity is still debated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
231

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2015

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2015

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2015

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

October 21, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 24, 2016

Completed
Last Updated

October 24, 2016

Status Verified

October 1, 2016

Enrollment Period

2 months

First QC Date

October 21, 2016

Last Update Submit

October 21, 2016

Conditions

Colonic Neoplasms

Outcome Measures

Primary Outcomes (1)

  • survival

    1 year

Interventions

Orcein stainingDRUG

Prognostic value of venous emboli detected by orcein staining

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients operated on for colon adenocarcinoma between 2004 and 2009 at the University Hospital of Amiens

You may qualify if:

  • All patients operated on for colon adenocarcinoma between 2004 and 2009 at the University Hospital of Amiens

You may not qualify if:

  • Non-operated patients
  • Patients operated on before 2004 or after 2009
  • Patients operated in another center
  • The other histological types
  • Vicinity of tumors invading the colon by contiguity
  • Colic metastasis
  • Patients whose blocks or blades were not found in the archives.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Amiens

Amiens, 80054, France

Location

MeSH Terms

Conditions

Colonic Neoplasms

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal Diseases

Study Officials

  • Denis CHATELAIN, MD, PhD

    CHU Amiens

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 21, 2016

First Posted

October 24, 2016

Study Start

February 1, 2015

Primary Completion

April 1, 2015

Study Completion

April 1, 2015

Last Updated

October 24, 2016

Record last verified: 2016-10

Locations

FR(1)